HALISTER: Achillion Soars After FDA Says Hepatitis C Trial Can Resume

Achillion Soars After FDA Says Hepatitis C Trial Can Resume

Alert: HALISTER Source: BN (Bloomberg News)

Tickers JNJ US (Johnson & Johnson) ACHN US (Achillion Pharmaceuticals Inc) 3400398Z US (HHS Food & Drug Administration) ABBV US (AbbVie Inc) IDIX US (Idenix Pharmaceuticals Inc)

People Brian Abrahams (Wachovia Securities Inc) Milind Deshpande (Achillion Pharmaceuticals Inc)

Topics Viral Hepatitis

To de-activate this alert, run {NLRT DEACT HALISTER <GO>}. To modify this alert, run {NLRT EDIT HALISTER <GO>}.

UUID: 7947283